Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 163.32% is 325% above its 5-year average of -72.59%, around the middle of its 5-year range (-173.28%–688.20%).
3.53% above its 12-month average of 157.75%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2.50%.
NET PROFIT MARGIN
163.32%
NET PROFIT MARGIN AVG TTM
157.75%
NET PROFIT MARGIN AVG 3Y
-42.34%
NET PROFIT MARGIN AVG 5Y
-72.59%
NET PROFIT MARGIN AVG 10Y
-71.55%
NET PROFIT MARGIN AVG 15Y
-50.35%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+3.53%
CURRENT VS 3Y AVG
+485.75%
CURRENT VS 5Y AVG
+324.98%
CURRENT VS 10Y AVG
+328.25%
CURRENT VS 15Y AVG
+424.35%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 787 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Fortress Biotech, Inc.
Market Cap
$67.93M
Net Profit Margin
163.32%
TTM Avg
157.75%
3Y Avg
-42.34%
5Y Avg
-72.59%
Market Cap
$67.52M
Net Profit Margin
-33044.00%
TTM Avg
-18819.13%
3Y Avg
-12177.01%
5Y Avg
-8726.92%
Market Cap
$69.31M
Net Profit Margin
-105.29%
TTM Avg
-106.48%
3Y Avg
-112.00%
5Y Avg
-95.88%
Market Cap
$69.19M
Net Profit Margin
17.18%
TTM Avg
-64.27%
3Y Avg
-50.52%
5Y Avg
-660.79%
Market Cap
$65.85M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-205.11%
5Y Avg
-156.77%
Market Cap
$70.30M
Net Profit Margin
-1.87%
TTM Avg
3.14%
3Y Avg
-4.53%
5Y Avg
-2.69%
Market Cap
$65.15M
Net Profit Margin
-13.72%
TTM Avg
-20.80%
3Y Avg
-11.88%
5Y Avg
-17.10%
Market Cap
$64.77M
Net Profit Margin
-235.00%
TTM Avg
-200.38%
3Y Avg
-100.19%
5Y Avg
-66.80%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | $67.93M | 163.32% | 157.75% | -42.34% | -72.59% |
| iBio, Inc. (IBIO)vs › | $67.52M | -33044.00% | -18819.13% | -12177.01% | -8726.92% |
| MindWalk Holdings Corp. (HYFT)vs › | $69.31M | -105.29% | -106.48% | -112.00% | -95.88% |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.19M | 17.18% | -64.27% | -50.52% | -660.79% |
| XBiotech Inc. (XBIT)vs › | $65.85M | 0.00% | 0.00% | -205.11% | -156.77% |
| Champions Oncology, Inc. (CSBR)vs › | $70.30M | -1.87% | 3.14% | -4.53% | -2.69% |
| InterCure Ltd. (INCR)vs › | $65.15M | -13.72% | -20.80% | -11.88% | -17.10% |
| Gossamer Bio, Inc. (GOSS)vs › | $64.77M | -235.00% | -200.38% | -100.19% | -66.80% |
| Cingulate Inc. (CING)vs › | $65.46M | 0.00% | 0.00% | 0.00% | 0.00% |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.56M | -22.52% | -11.22% | -69.63% | -131.75% |
Operating Margin
-111.0%
Net Profit Margin
163.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -2.50% |
| 2026-03-31 | 688.20% |
| 2025-12-31 | -24.49% |
| 2025-09-30 | 33.18% |
| 2025-06-30 | 94.35% |
| 2025-03-31 | -80.55% |
| 2024-12-31 | -44.74% |
| 2024-09-30 | -87.96% |
| 2024-06-30 | -73.50% |
| 2024-03-31 | -118.32% |
| 2023-12-31 | -46.52% |
| 2023-09-30 | -14.52% |
| 2023-06-30 | -142.51% |
| 2023-03-31 | -173.28% |
| 2022-12-31 | -164.28% |
| 2022-09-30 | -136.20% |
| 2022-06-30 | -113.08% |
| 2022-03-31 | -65.87% |
| 2021-12-31 | -172.71% |
| 2021-09-30 | -98.56% |
| 2021-06-30 | -19.81% |
| 2021-03-31 | -76.14% |
| 2020-12-31 | -38.51% |
| 2020-09-30 | -164.08% |
| 2020-06-30 | -140.78% |
| 2020-03-31 | -95.76% |
| 2019-12-31 | -139.19% |
| 2019-09-30 | -130.60% |
| 2019-06-30 | -141.60% |
| 2019-03-31 | 21.49% |
| 2018-12-31 | 15.94% |
| 2018-09-30 | -26.12% |
| 2018-06-30 | -33.85% |
| 2018-03-31 | -37.92% |
| 2017-12-31 | -22.98% |
| 2017-09-30 | -57.83% |
| 2017-06-30 | -34.25% |
| 2017-03-31 | -26.82% |
| 2016-12-31 | -138.18% |
| 2016-09-30 | -1331.38% |
| 2016-06-30 | -559.55% |
| 2016-03-31 | -1849.24% |
| 2015-12-31 | -3560.95% |
| 2015-09-30 | -72644.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | -2411.20% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
